Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart device data drive: 1,000 patients help shape Tomorrow's implants

NCT ID NCT05061862

Knowledge-focused Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gathers information from 1,000 adults who have or will receive a cardiac implantable electronic device (CIED) for heart rhythm problems like bradycardia or tachycardia. Researchers collect details about the device, the implant procedure, and patient characteristics to support the development of future CIED products and procedures. No new treatments or therapies are being tested—only data is collected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2022

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects who meet all inclusion criteria and none of the exclusion criteria

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subject is at least 18 years of age. 2. Subject is willing and able to provide written informed consent. 3. Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements Exclusion Criteria: 1. Subject is unwilling or unable to comply with study procedures as defined in the protocol. 2. Subject with a medical condition that precludes the patient from participation in the opinion of the investigator. 3. Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arrhythmias, cardiac are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac Bradycardia cardiac rhythm disease Tachycardia ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arrhythmias, cardiac Bradycardia Tachycardia

Contacts and locations

Locations

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

  • Georgia Arrhythmia Consultants

    Macon, Georgia, 31201, United States

  • Inova Fairfax Hospital

    Falls Church, Virginia, 22042, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, 17604, United States

  • Oregon Health & Science University Hospital

    Portland, Oregon, 97239, United States

  • Sentara Norfolk General Hospital

    Norfolk, Virginia, 23507, United States

  • The Cardiac & Vascular Institute

    Gainesville, Florida, 32605, United States

  • UZ Leuven - Campus Gasthuisberg

    Leuven, Belgium

  • University of Virginia Medical Center

    Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.